Myotonic Dystrophy Pipeline Appears Robust With 25+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
15 févr. 2023 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Feb. 15, 2023 (GLOBE NEWSWIRE) -- Myotonic Dystrophy Pipeline Appears Robust With 25+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight Myotonic...